SMTL ID : 1lyb.2 (2 other biounits)

CRYSTAL STRUCTURES OF NATIVE AND INHIBITED FORMS OF HUMAN CATHEPSIN D: IMPLICATIONS FOR LYSOSOMAL TARGETING AND DRUG DESIGN

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.50 Å

Oligo State

hetero-1-1-mer

Ligands

1 x IVA- VAL- VAL- STA- ALA- STA: PEPSTATIN(Non-covalent)

IVA-VAL-VAL-STA-ALA-STA.1: 16 residues within 4Å: Chain A: V.31, D.33, G.35, S.36, H.77, Y.78, G.79, S.80 Chain B: Y.100, D.126, G.128, T.129, S.130, E.155, I.206, I.215 15 PLIP interactions: 7 interactions with chain A, 8 interactions with chain B Hydrophobic interactions: A:V.31, B:Y.100, B:T.129, B:I.206 Hydrogen bonds: A:G.35, A:H.77, A:G.79, A:S.80, A:S.80, A:S.80, B:G.128, B:T.129, B:T.129, B:S.130, B:S.130

1 x NAG- NAG- BMA- MAN: alpha-D-mannopyranose-(1-6)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose

NAG-NAG-BMA-MAN.2: 10 residues within 4Å: Chain A: K.69, N.70, T.72, L.87 Chain B: V.9, R.36, N.40, N.41, V.42, L.43 2 PLIP interactions: 2 interactions with chain B Hydrogen bonds: B:N.41, B:N.41, B:N.41, B:N.40 Hydrophobic interactions: B:N.40

1 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)

NAG.3: 2 residues within 4Å: Chain B: Y.92, N.94 No protein-ligand interaction detected (PLIP)

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Baldwin, E.T. et al., Crystal structures of native and inhibited forms of human cathepsin D: implications for lysosomal targeting and drug design. Proc.Natl.Acad.Sci.USA (1993)

Release Date

1994-01-31

Peptides

CATHEPSIN D: A
CATHEPSIN D: B

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

CATHEPSIN D

CATHEPSIN D

Related Entries With Identical Sequence